Peters Dorothea

Long-term Impact of Immediate Versus Delayed Treatment of Early Glaucoma: Results From the Early Manifest Glaucoma Trial.

At study end, percentages of eyes with VI or blindness were slightly higher in the treated group than in the untreated control group, 12.1% vs 11.0%, and 9.4.% vs 6.1% respectively, as were subjects with VI in at least one eye, 19.5% vs 18.7%.

Guidelines for the management of open-angle glaucoma: National Program Area Eye Diseases, National Working Group Glaucoma.

Charles Bonnet Syndrome in Patients with Open-Angle Glaucoma: Prevalence and Correlation to Visual Field Loss.

Charles Bonnet Syndrome was not a rare condition in patients with glaucoma.

Three cases of Charles Bonnet Syndrome in patients with advanced glaucomatous visual field loss but preserved visual acuity.

Charles Bonnet syndrome can occur in glaucoma despite preserved visual acuity. Awareness of this relation is desirable among clinicians, as it will improve communication with patients.

A prospective study on effectiveness of elevated intraocular pressure as a criterion for glaucoma referrals by optometric practitioners in Sweden.

CONCLUSION: The overall predictive value of the referrals was poor.

Charles Bonnet Syndrome Adversely Affects Vision-Related Quality of Life in Patients with Glaucoma.

Charles Bonnet syndrome had a significant negative association to VRQoL in patients with glaucoma.

Threat to fixation and vision-related quality of life in early open-angle glaucoma - results from the Glaucoma Intensive Treatment Study.

The presence of TTF did not influence VRQoL, as measured by the NEI-VFQ-25, in this relatively large group of patients with mainly early glaucoma.

Impact of mono- or multitherapy on ocular surface health and quality of life after 5 years of follow-up in the Glaucoma Intensive Treatment Study (GITS).

We found no differences in objective or subjective impact on ocular surface between the two randomization arms.

Threat to fixation and vision-related quality of life in patients with open-angle glaucoma.

Overlapping TTF was not an independent predictor of VRQoL after controlling for VFL severity. By contrast, IVF-MD emerged as the most significant predictor of VRQoL.

Response to Comment on: Long-term Impact of Immediate Versus Delayed Treatment of Early Glaucoma: Results From the Early Manifest Glaucoma Trial.

Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up.

Our results support the widespread, albeit arbitrary, use of a better-eye visual field of <50% as an important threshold for a significant reduction in VRQOL.

Reply: To PMID 25537196.

Threat to fixation at diagnosis and lifetime risk of visual impairment in open-angle glaucoma.

Including TTF in the assessment of risk for glaucoma blindness did not add any important information when the stage of VFL was taken into account.